FindTrial
Sign In

Effect of 2-Aminoethanesulfonic Acid on the lipid and inflammatory profile

Effect of 2-Aminoethanesulfonic Acid on the lipid and inflammatory profile in patients with Cardiac Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903314058N2
Enrollment
Unknown
Registered
2010-06-21
Start date
2008-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lipid and inflammatory profile.

Interventions

Intervention 1: Capsule of starch -500 mg- Three times Per day - during 14 days. Intervention 2: Three Times Per day - copsule of Taurine 500 mg -during 14 days.
Placebo
Prevention
Capsule of starch -500 mg- Three times Per day - during 14 days
Three Times Per day - copsule of Taurine 500 mg -during 14 days

Sponsors

investigator
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1- Heart failure functional class II & III 2- Left ventricular ejection fraction in less than 50% 3- All of them have some protocol treatment (PCI - PTCA - open heart surgery) 3- Subjects should not have received a variety of vitamins and minerals 4-should not be sensitive to Sulfur 5-should not have disability

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
C-reactive protein(CRP). Timepoint: 2 Weeks After & Before suplemmentaition. Method of measurement: Particle –Enhanced Immunoturbidimetric assay-Methods of Latex.;Total of Cholesterol. Timepoint: 2 Weeks After & Before suplemmentaition. Method of measurement: Methods of Enzymatic.;Triglycerides. Timepoint: 2 Weeks After & Before suplemmentaition. Method of measurement: Methods of Enzymatic.;Low density Lipoprotein of Cholesterol. Timepoint: 2 Weeks After & Before suplemmentaition. Method of measurement: Methods of Enzymatic.;High density Lipoprotein of Cholesterol. Timepoint: 2 Weeks After & Before suplemmentaition. Method of measurement: Methods of Enzymatic.—

Secondary

MeasureTime frame
Diastolic Blood Presure. Timepoint: 2weeks After And Before suplemmentaition. Method of measurement: Stethoscope - Treadmill - Instrument of control Blood presure.;Systolic Blood Presure. Timepoint: 2weeks After And Before suplemmentaition. Method of measurement: Stethoscope - Treadmill - Instrument of control Blood presure.;2-Aminoethanesulfonic Acid. Timepoint: 2 Weeks After & Before suplemmentaition. Method of measurement: HPLC (High Chromatography Reverse).;Heart Rate. Timepoint: 2weeks After And Before suplemmentaition. Method of measurement: Stethoscope - Treadmill - Instrument of control Blood presure.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Valiollah Dabidi Roshan

College of physical education and sport sciences,Babolsar, university of Mazandaran

vdabidiroshan@yahoo.com-+98 11 2526 3818

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026